Article
A novel intermediate mucolipidosis II/IIIαβ caused by GNPTAB mutation in the cytosolic N-terminal domain.
European journal of human genetics : EJHG - 1 May 2014
Leroy Jules G, Sillence David, Wood Tim, Barnes Jarrod, Lebel Robert Roger, Friez Michael J, Stevenson Roger E, Steet Richard, Cathey Sara S
Abstract excerpt
Mucolipidosis (ML) II and ML IIIα/β are allelic autosomal recessive metabolic disorders due to mutations in GNPTAB. The gene encodes the enzyme UDP-GlcNAc-1-phosphotransferase (GNPT), which is critical to proper trafficking of lysosomal acid hydrolases. The ML phenotypic spectrum is dichotomous. Criteria set for defining ML II and ML IIIα/β are inclusive for all but the few patients with phenotypes that span the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
